Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28149076 | 0.75 | — | — | |
| SCHEMBL9625475 | 0.72 | SHBG (0.31) | — | |
| SCHEMBL5723992 | 0.72 | SHBG (0.31) | — | |
| SCHEMBL493847 | 0.71 | — | — | |
| SCHEMBL7739593 | 0.70 | CYP2D6 (0.31) | — | |
| SCHEMBL258304 | 0.70 | CYP2D6 (0.31) | — | |
| SCHEMBL258217 | 0.70 | CYP2D6 (0.31) | — | |
| SCHEMBL7741445 | 0.70 | CYP2D6 (0.31) | — | |
| SCHEMBL7737776 | 0.70 | CYP2D6 (0.31) | — | |
| SCHEMBL5057406 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968273-B2 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | NANOSYS, INC. (US) | 2011-06-28 | — | — | US | claimed |
| US-20100155786-A1 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | NANOSYS, INC. (US) | 2010-06-24 | — | — | US | claimed |
| EP-2052407-A2 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS | Nanosys, Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| WO-2008013959-A2 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS | NANOSYS, INC. (US) | 2008-01-31 | — | — | WO | claimed |
| CN-110121515-A | Fluorine-containing active energy ray curable resin, surfactant, active energy ray-curable resin composition and cured coating film | DIC株式会社 | 2019-08-13 | — | — | CN | disclosed |
| CN-105754099-B | Composition and polymer | 旭化成株式会社 | 2018-09-18 | — | — | CN | disclosed |
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | CREATIVE NAIL DESIGN, INC. (US) | 2017-03-02 | — | — | US | disclosed |
| CN-103502315-B | Composition and polymer | 旭化成株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-105754099-A | Composition and polymer | 旭化成株式会社 | 2016-07-13 | — | — | CN | disclosed |
| EP-2052407-B1 | METHODS FOR FORMING NANOSTRUCTURE MONOLAYERS | SANDISK CORP (US) | 2015-07-01 | — | — | EP | disclosed |
| CN-104610222-A | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORP | 2015-05-13 | — | — | CN | disclosed |
| US-8981452-B2 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | SANDISK CORPORATION (US) | 2015-03-17 | — | — | US | disclosed |
| US-20140035011-A1 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS | SANDISK CORPORATION (US) | 2014-02-06 | — | — | US | disclosed |
| US-8558304-B2 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | SANDISK CORPORATION (US) | 2013-10-15 | — | — | US | disclosed |
| US-20110204432-A1 | Methods and Devices for Forming Nanostructure Monolayers and Devices Including Such Monolayers | NANOSYS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| US-7968273-B2 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | NANOSYS, INC. (US) | 2011-06-28 | — | — | US | disclosed |
| US-20100155786-A1 | Methods and devices for forming nanostructure monolayers and devices including such monolayers | NANOSYS, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| EP-2052407-A2 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS | Nanosys, Inc. (US) | 2009-04-29 | — | — | EP | disclosed |
| US-20080108773-A1 | Polyurethane dispersions containing POSS nanoparticles | SOUTHERN MISSISSIPPI, UNIVERSITY OF, THE | 2008-05-08 | — | — | US | disclosed |
| WO-2008013959-A2 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS | NANOSYS, INC. (US) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | POLR1C, PIK3C3, NACA | SLC6A4 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.